Gianna Melillo

New research indicates that migraine frequency may be inversely linked with a diet high in anti-inflammatory properties.

Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health (GPBCH), describes how the organization first became involved with the National Diabetes Prevention Program.

David Ramsey, MD, PhD, MPH, outlines why patients with diabetes should undergo regular eye examinations.

Researchers compared drug costs among hospitals, specialty pharmacies, and physician offices.

Speaking during a webinar presented by the National Alliance of Healthcare Purchaser Coalitions, experts weighed the pros and cons of employer high-deductible health plans (HDHPs) and outlined steps to address challenges raised.

Data showed erenumab helped improve migraine functional impact when compared with placebo.

James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, lists potential solutions to bolster ophthalmic trauma care in the United States.

Migraineurs and those with tension-type headaches reported poorer physical and cognitive work ability compared with their headache-free counterparts.

Patients who utilized a patient-reported outcome (PRO) symptom measurement tool reported superior postdischarge outcomes after lung cancer surgery compared with those who received usual care.

The National Clinical Care Commission (NCCC) issued 39 recommendations to improve diabetes prevention and care in the United States.

Patients with non–small cell lung cancer (NSCLC) reported superior mental health well-being during the COVID-19 pandemic compared with a control population that did not have cancer.

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, shares his thoughts on long COVID-19 among those with type 2 diabetes and the rise of new-onset cases of type 1 diabetes throughout the pandemic.

The national coverage determination will help detect early non-small cell lung cancer, CMS said.

Individuals in Taiwan who suffer from migraine were at an increased risk of developing neovascular age-related macular degeneration.

Using data from a meta-analysis, researchers determined tumor-stroma ratio could serve as a survival predictor in non–small cell lung cancer (NSCLC).

Data from SURPASS-5 show Eli Lilly's glucagon-like peptide-1 receptor agonist tirzepatide helped improve glycemic control when taken with insulin glargine.

Findings of the largest genome-wide association study conducted among migraineurs to date revealed novel risk factors for the condition, stratified by aura presence.

Anne Barmettler, MD, an associate professor of ophthalmology, visual sciences, and plastic surgery at Montefiore Medical Center, outlines adverse events patients taking teprotumumab for thyroid eye disease may experience.

Data from a 10-year follow-up study showed declining kidney function is significantly associated with dementia risk among older adults.

The overdiagonsis identified in the current study also led to overtreatment in this population, authors found.

Researchers assess the role of cognitive behavioral therapy in treating pediatric migraine.

Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains how older patients with glaucoma may lose nerve fiber layer at a quicker rate than younger patients.

Results of a retrospective study conducted in Spain found that dialectical-behavioral therapy skills training can help mitigate polypharmacy in those with borderline personality disorder.

A meta-analysis on first-line treatment for non–small cell lung cancer (NSCLC) in clinical trials revealed that inclusion of dexamethasone along side chemotherapy and PD-L1 inhibitors yielded benefits in this patient population.

New survey findings reveal a significant association between migraine and irritable bowel syndrome.

The rise in popularity of genetic testing brings along a myriad of challenges ranging from concerns on data privacy to insurance coverage, but, when utilized correctly, it could mark a step forward for significant advancements in individual and population health.

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses some of the challenges of treating pediatric patients with type 1 or type 2 diabetes.

The FDA has cleared the first tubeless automated insulin delivery system with a smartphone app control.

An analysis of data collected in 2018 shows that more work is needed to address unmet needs in episodic migraine.

Findings from 2 studies conducted among German and US children highlight the growing incidence of type 1 diabetes (T1D) among children throughout the COVID-19 pandemic.